Last quarter (Q3 2025), Teva Pharmaceutical's total revenue was $4.48B, an increase of 3.44% from the same quarter last year. In Q3, Teva Pharmaceutical's net income was $433.00M. See Teva Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 16.54B	$ 15.85B	$ 14.93B	$ 15.88B	$ 16.66B
Gross Profit	$ 8.06B	$ 7.64B	$ 6.97B	$ 7.59B	$ 7.73B
Operating Expenses	$ 8.37B	$ 7.21B	$ 9.17B	$ 5.88B	$ 11.30B
Depreciation and Amortization	$ 1.06B	$ 1.15B	$ 1.31B	$ 1.33B	$ 1.56B
EBITDA	$ 4.43B	$ 1.56B	$ -925.00M	$ 4.41B	$ 4.61B
Operating Income	$ -303.00M	$ 433.00M	$ -2.20B	$ 1.72B	$ -3.57B
Other Income/Expenses	$ -980.00M	$ -1.05B	$ -945.00M	$ -1.05B	$ -359.00M
Pretax Income	$ -1.28B	$ -622.00M	$ -3.14B	$ 667.00M	$ -3.93B
Net Income	$ -1.64B	$ -559.00M	$ -2.45B	$ 417.00M	$ -3.99B
Per Share Metrics
Basic EPS	$ -1.45	$ -0.50	$ -2.20	$ 0.38	$ -3.64
Diluted EPS	$ -1.45	$ -0.50	$ -2.20	$ 0.38	$ -3.64
Weighted Average Shares Outstanding	1.13B	1.12B	1.11B	1.10B	1.09B
Weighted Average Shares Outstanding (Diluted)	1.13B	1.12B	1.11B	1.11B	1.09B

Currency in USD

Teva Pharmaceutical Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing